
Voglimin-M 0.2 Tablet SR
Marketer
Orris Pharmaceuticals
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Voglimin-M 0.2 Tablet SR
Diabetol-Duo 0.2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes to manage blood glucose levels. Diabetol-Duo 0.2mg Extended-Release tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage will be determined and potentially adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication is only one component of a comprehensive diabetes management plan, which should also encompass dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Potential side effects include gastrointestinal upset (nausea, altered taste, anorexia, flatulence, abdominal pain, diarrhea), and dermatological reactions (rash). These are typically transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention. Your doctor can offer strategies to mitigate or manage any adverse effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to track blood cell counts and liver function.
Uses of Voglimin-M 0.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglimin-M 0.2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimin-M 0.2mg Extended-Release tablets should be taken with a meal.
Common Side effects of Voglimin-M 0.2 Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglimin-M 0.2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Voglimin-M 0.2mg sustained-release tablet should be swallowed whole with food; do not crush, chew, or break it.
How Voglimin-M 0.2 Tablet SR works:
Voglimin-M 0.2mg sustained-release tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimin-M 0.2 Tablet SR and alcohol is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Voglimin-M 0.2 SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglimin-M 0.2mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglimin-M 0.2 Tablet SR. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Voglimin-M 0.2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Data on Voglimin-M 0.2 Tablet SR use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Voglimin-M 0.2 Tablet SR :
Should you forget to take your Voglimin-M 0.2 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Voglimin-M 0.2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
